UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
FUSN holding history
Fusion Pharmaceuticals Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FUSN overviewAll 13F holders of FUSNFull Q4 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −213,107−100.0% | Sold out | Holders |
| Q4 2023 | 213,107 | $2.05M | 0.1% | −61,461−22.4% | Reduced | Holders |
| Q3 2023 | 274,568 | $713.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 274,568 | $1.28M | <0.1% | +32,542+13.4% | Added | Holders |
| Q1 2023 | 242,026 | $912.4K | <0.1% | +242,026 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −17,286−100.0% | Sold out | Holders |
| Q3 2022 | 17,286 | $52.0K | <0.1% | +17,286 | New | Holders |